Out August 6, 2019. Pre-order here.
May 8, 2019 – Allison Martell and Anna Mehler Paperny, Reuters
A tiny, little-known government agency is ramping up regulation of Canada’s pharmaceutical industry, seeking to rein in prices for patented drugs that are among the highest in the world, according to industry sources and a Reuters analysis of government data.
February 6, 2019 – Allison Martell and Anna Mehler Paperny, Reuters
Canadian pharmaceutical industry lobby groups, in an effort to head off a planned crackdown on prescription drug prices, offered to give up C$8.6 billion ($6.6 billion) in revenue over 10 years, freeze prices or reduce the cost of treating rare diseases, according to interviews and documents seen by Reuters.
Canada’s Liberal government will propose a limited expansion to the country’s universal healthcare system in the spring budget, to cover part of the cost of prescription drugs, sources with direct knowledge of the matter told Reuters.
The modest broadening of the healthcare program is set to become one of Prime Minister Justin Trudeau’s key campaign promises ahead of the October election, which is shaping up to be a close fight.
The government would not commit to meeting 100 percent of the cost of prescription drugs for those who have no insurance through their workplace, the sources said. That suggests the government is leaning toward a narrower, more insurance industry-friendly model of pharmacare, as it is called, than that recommended by a government health committee last year.
A spokesman for Finance Minister Bill Morneau declined to comment.
The U.S. Justice Department said on Tuesday it will pursue the extradition of Huawei Technologies Co Ltd’s [HWT.UL] Chief Financial Officer Meng Wanzhou, arrested in Canada in December on allegations she participated in a conspiracy to defraud banks.
Amid threats to the safety of Saudi teenager Rahaf Mohammed, who was granted asylum in Canada, the Toronto agency that is helping her has hired a security guard to ensure “she is never alone” as she starts a normal life, its executive director said on Tuesday.